1 September 2007 in Arquivos de Neuro-Psiquiatria
Bilateral and symmetric globus-pallidus hyperintensities are observed on T1-weighted MRI in most of the patients with chronic liver failure, due to manganese accumulation. We report a 53-year-old man, with rapid onset parkinsonism-dementia complex associated with accumulation of manganese in the brain, secondary to liver failure. A brain MRI was performed and a high signal on T1-weighted images was seen on globus-pallidus, as well as on T2-weighted images on the hemispheric white-matter. He was referred to a liver-transplantation. The patient passed away on the seventh postoperative day. Our findings support the concept of the toxic effects of manganese on the globus-pallidus. The treatment of this form of parkinsonism is controversial and liver-transplantation should not be considered as first line treatment but as an alternative one.
1 January 2022 in Parkinson's Disease
Introduction. Brain SPECT with 99mTc‐TRODAT‐1 (SPECT‐TRODAT) may be a useful tool in the differential diagnosis of Parkinsonism. Objective. To compare results of SPECT‐TRODAT with clinical findings in patients with Parkinsonism. Methods. We evaluated 153 outpatients. SPECT‐TRODAT results were visually analyzed into normal, abnormal, symmetric, and asymmetric, and according to the degree of impairment into mild, moderate, marked, and severe (1–4). Results. A direct relationship was found between motor scores severity (MDS‐UPDRS‐III) and SPECT‐TRODAT‐reduced binding in general, in the group of patients with synucleinopathies (rho = 0.258, p = 0.005), especially in patients with Parkinson’s disease (rho = 0.204, p = 0.049). Changes in SPECT‐TRODAT had high correspondence with symmetry in all Parkinsonism. When comparing groups to the correspondence predominantly bilateral or unilateral impairment in SPECT, there was a difference between patients with SNP (p = 0.041) and between this group and patients with secondary Parkinsonism (SP) (p < 0.0001). It was handy in differentiating drug‐induced Parkinsonism from synucleinopathies. In the group of drug‐induced Parkinsonism, younger people were the ones who showed the most significant reductions in radiotracer uptake. In this group, nonmotor signs resulted in examinations with more significant reductions in radiotracer uptake. When the scans without alterations and those that did not correspond to the symmetry were considered negative, SPECT‐TRODAT’s accuracy and specificity to differentiate PD from other forms of Parkinsonism were low. There was an inverse correlation between the severity of the SPECT‐TRODAT result and the absence of nonmotor signs in patients with drug‐induced Parkinsonism. Conclusion. The authors concluded that the SPECT with 99mTc‐TRODAT‐1 was mainly useful in differentiating between synucleinopathies and secondary Parkinsonism.
26 October 2018 in Movement Disorders Clinical Practice
FGFrancisco M.B. Germiniani
Francisco M.B. Germiniani
28 September 2022 in The Open Neurology Journal
Introduction: Patients with essential tremor (ET) have 3.5 times greater risk of developing Parkinson's disease (PD) throughout their lives, also known as PD with antecedent ET (ET-PD). Single photon emission computed tomography with radiotracer imaging of dopamine transporters (TRODAT-SPECT) can help differentiate these two diseases. Method: Relate the results of TRODAT-SPECT imaging in patients with ET to potential progress to ET-PD. Thirty-six patients with ET were evaluated by neurological examination, the Archimedes spiral, and the MDS-UPDRS III scale on two occasions, after a mean interval of three years. SPECT was performed on all patients after the first visit. Results: Overall, six patients (16.6%) progressed clinically to ET-PD. Patients with ET-PD were older, and the age of tremor onset was later. The ET-PD group scored higher on the MDS-UPDRS III scale, especially for the presence of bradykinesia. SPECT imaging was altered in 83.3% of the ET-PD patients compared to 33% of the ET patients (p=0.034). Changes on the SPECT with asymmetrical hypouptake suggested progress to ET-PD (p=0.025). Conclusion: Advanced age at the onset of tremor, the presence of bradykinesia, and asymmetrical alterations in SPECT may be related to progression to PD in patients with ET. Changes in neuroimaging suggest that SPECT-TRODAT can be used to predict progression to PD in selected patients.
1 January 2024 in Neuroimmunology Reports
GMGiovanna Thais Torques Moretti
Giovanna Thais Torques Moretti
GFGeorgette Mouchaileh Evangelista Ferreira
Georgette Mouchaileh Evangelista Ferreira
JAJessica Pizatto de Araujo
Jessica Pizatto de Araujo
1 February 2022 in Neurology